Cargando…
Bone marrow mammaglobin-1 (SCGB2A2) immunohistochemistry expression as a breast cancer specific marker for early detection of bone marrow micrometastases
Despite all the advances in the management of breast cancer (BC), patients with distance metastasis are still considered incurable with poor prognosis. For that reason, early detection of the metastatic lesions is crucial to improve patients’ life span as well as quality of life. Many markers were p...
Autores principales: | Talaat, Iman Mamdouh, Hachim, Mahmood Yaseen, Hachim, Ibrahim Yaseen, Ibrahim, Ramez Abd El-Razak, Ahmed, Mohamed Abd El Rahman, Tayel, Hanan Yehia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400628/ https://www.ncbi.nlm.nih.gov/pubmed/32747636 http://dx.doi.org/10.1038/s41598-020-70012-2 |
Ejemplares similares
-
The prognostic value of ephrin type-A2 receptor and Ki-67 in renal cell carcinoma patients: An Immunohistochemical and Bioinformatical Approach; A STROBE - compliant article
por: Talaat, Iman Mamdouh, et al.
Publicado: (2020) -
M1 Polarization Markers Are Upregulated in Basal-Like Breast Cancer Molecular Subtype and Associated With Favorable Patient Outcome
por: Hachim, Mahmood Yaseen, et al.
Publicado: (2020) -
Bone marrow micrometastases in early breast cancer–30-year outcome
por: Mansi, J, et al.
Publicado: (2016) -
Toxicogenomic analysis of publicly available transcriptomic data can predict food, drugs, and chemical-induced asthma
por: Hachim, Mahmood Yaseen, et al.
Publicado: (2019) -
Bone marrow micrometastases and circulating tumor cells: current aspects and future perspectives
por: Müller, Volkmar, et al.
Publicado: (2004)